NCT01492400
- Conditions
- Eye Diseases, Macular Degeneration, Macular Edema, +2 more
- Locations
-
- Arlington, Texas, United States
- Brussels, Belgium
- Copenhagen, Denmark
- Glostrup Municipality, Denmark
Clinical trial condition
Macular Degeneration
Explore clinical trials studying Macular Degeneration. Study availability and eligibility vary by location and protocol.
392 public trials
45 recruiting studies
Macular Degeneration trial results
NCT01903720
- Conditions
- Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +8 more
- Locations
-
- Seoul, South Korea
NCT01660802
- Conditions
- Eye Diseases, Macular Degeneration, Macular Edema, +2 more
- Locations
-
- Beijing, China
NCT01805323
- Conditions
- Eye Diseases, Macular Degeneration, Macular Edema, +2 more
- Locations
-
- Québec, Quebec, Canada
NCT02040220
- Conditions
- Cardiovascular Diseases, Embolism and Thrombosis, Eye Diseases, +8 more
- Locations
-
- Multiple Locations, Japan
NCT03904056
- Conditions
- Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +9 more
- Locations
-
Not specified
Completed
The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema
NCT01564108
- Conditions
- Eye Diseases, Macular Degeneration, Macular Edema, +4 more
- Locations
-
- Moorfields Eye Hospital NHSFT Research and Treatment Centre London, United Kingdom
Completed
Safety and Effect on Central Retinal Thickness of BI 1026706 in Patients With Diabetic Macular Edema
NCT02732951
- Conditions
- Eye Diseases, Macular Degeneration, Macular Edema, +2 more
- Locations
-
- Brussels-UNIV Brugmann -Horta Brussels, Belgium
- Leuven - UNIV UZ Leuven (Sint-Rafaël) Leuven, Belgium
- HOP Nord Marseille, France
- HOP Hôtel-Dieu Nantes, France
- Conditions
- Eye Diseases, Macular Degeneration, Retinal Degeneration, +2 more
- Locations
-
- Multiple Locations, Canada
NCT02259088
- Conditions
- Diabetes Mellitus, Diabetic Macular Edema, Endocrine System Diseases, +15 more
- Locations
-
- Novartis Investigative Site Beijing, Beijing Municipality, China
- Novartis Investigative Site Beijing, Beijing Municipality, China
- Novartis Investigative Site Beijing, Beijing Municipality, China
- Novartis Investigative Site Guangzhou, Guangdong, China